{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T03:15:27Z","timestamp":1773803727962,"version":"3.50.1"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T00:00:00Z","timestamp":1608681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Mitral valve regurgitation (MR) has a high incidence in the western world, and mortality is high for untreated severe MR. Catheter based repair was introduced with MitraClip in 2003, and some additional devices later came into the market. To expand the transcatheter treatment options for mitral valve disease, the first transcatheter mitral valve implantation (TMVI) was performed by S\u00f8ndergaard et al. 2012, only 10 years after the first transcatheter aortic valve implantation (TAVI), however, the development has been much slower for the TMVI than for TAVI. From 2012, studies were started for several devices to prove feasibility and safety. However, there were big challenges in valve design; delivery systems and anchoring in addition to anatomical issues (avoid LVOT obstruction and paravalvular leak, big size of annulus). The main valves in studies were CardiaQ (later bought by Edwards Lifesciences, Irvine, United States), Tiara (Neovasc Inc., Richmond, Canada), Twelve (later Intrepid, Medtronic, MN, United States) and Tendyne\u2122 (Abbott, MN, United States). I will focus on the Tendyne\u2122 valve that is the only CE approved transcatheter mitral valve implant. It is available in a large number of sizes and is repositionable and retrievable. The results for the 100 first patients included in the early feasibility study (EFS) at 1 and 2 years are promising. Initially feasible for MR, but further investigations show promising results also for implant in mitral annular calcification.<\/jats:p>","DOI":"10.3389\/fcvm.2020.592909","type":"journal-article","created":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T09:05:35Z","timestamp":1608714335000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Current Devices in TMVI and Their Limitations: Focus on Tendyne"],"prefix":"10.3389","volume":"7","author":[{"given":"Gry","family":"Dahle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,12,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1093\/eurheartj\/ehm001","article-title":"What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery?","volume":"28","author":"Mirabel","year":"2007","journal-title":"Eur Heart J."},{"key":"B2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jacc.2013.08.723","article-title":"Prevalence and outcomes of unoperated patients with severe symptomatic mitral regurgitation and heart failure: comprehensive analysis to determine the potential role of MitraClip for this unmet need","volume":"63","author":"Goel","year":"2014","journal-title":"J Am Coll Cardiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/S0140-6736(06)69208-8","article-title":"Burden of valvular heart diseases: a population-based study","volume":"368","author":"Nkomo","year":"2006","journal-title":"Lancet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"724","DOI":"10.21037\/acs.2018.10.06","article-title":"Complexities of transcatheter mitral valve replacement (TMVR) and why it is not transcatheter aortic valve replacement (TAVR)","volume":"7","author":"Wyler von Ballmoos","year":"2018","journal-title":"Ann Cardiothorac Surg."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e002135","DOI":"10.1161\/CIRCINTERVENTIONS.115.002135","article-title":"First-in- human case of transfemoral CardiAQ mitral valve implantation","volume":"8","author":"S\u00f8ndergaard","year":"2015","journal-title":"Circ Cardiovasc Interv."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/j.athoracsur.2013.06.051","article-title":"Isolated mitral valve surgery risk in 77,836 patients from the society of thoracic surgeons database","volume":"96","author":"Chatterjee","year":"2013","journal-title":"Ann Thorac Surg."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1016\/j.jacc.2017.02.045","article-title":"Transcatheter mitral valve replacement: insights from early clinical experience and future challenges","volume":"69","author":"Regueiro","year":"2017","journal-title":"J Am Coll Cardiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jacc.2016.10.068","article-title":"Transcatheter mitral valve replacement for patients with symptomatic mitral regurgitation: a global feasibility trial","volume":"69","author":"Muller","year":"2017","journal-title":"J Am Coll Cardiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.jacc.2018.12.066","article-title":"Initial feasibility study of a new transcatheter mitral prosthesis: the first 100 patients","volume":"73","author":"Sorajja","year":"2019","journal-title":"J Am Coll Cardiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jcin.2018.10.056","article-title":"Transcatheter mitral valve replacement with a new supra-annular valve: first-in-human experience with the AltaValve system","volume":"12","author":"Nunes","year":"2019","journal-title":"JACC Cardiovasc Interv."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/j.jcmg.2016.01.017","article-title":"Predicting LVOT obstruction after TMVR","volume":"9","author":"Wang","year":"2016","journal-title":"JACC Cardiovasc Imaging."},{"key":"B12","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/ejcts\/ezaa109","article-title":"A tensed tendyne","volume":"58","author":"Grinberg","year":"2020","journal-title":"Eur J Cardiothorac Surg."},{"key":"B13","doi-asserted-by":"publisher","first-page":"E37","DOI":"10.1002\/ccd.28210","article-title":"Successful repositioning of apically tethered transcatheter mitral valve replacement in the off-bypass, beating heart","volume":"95","author":"Aktuerk","year":"2020","journal-title":"Catheter Cardiovasc Interv."},{"key":"B14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11936-018-0694-z","article-title":"Transcatheter mitral valve planning and the Neo-LVOT: utilization of virtual simulation models and 3D printing","volume":"20","author":"Kohli","year":"2018","journal-title":"Curr Treat Options Cardiovasc Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1016\/j.jcin.2020.05.010","article-title":"Neo-Left ventricular outflow tract modification with alcohol septal ablation before tendyne transcatheter mitral valve replacement","volume":"13","author":"Ukaigwe","year":"2020","journal-title":"JACC Cardiovasc Interv."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1016\/j.jcin.2018.06.019","article-title":"LAMPOON to facilitate tendyne transcatheter mitral valve replacement","volume":"11","author":"Khan","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"B17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3389\/fcvm.2019.00044","article-title":"Clinical valve thrombosis and subclinical leaflet thrombosis following transcatheter aortic valve replacement: is there a need for a patient-tailored antithrombotic therapy?","volume":"6","author":"Rosseel","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1016\/j.jacc.2015.09.022","article-title":"Bioprosthetic valve thrombosis versus structural failure: clinical and echocardiographic predictors","volume":"66","author":"Egbe","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.1093\/eurheartj\/ehx303","article-title":"Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the european association of percutaneous cardiovascular interventions (EAPCI) endorsed by the european society of cardiology (ESC) and the european association for cardio-thoracic surgery (EACTS)","volume":"38","author":"Capodanno","year":"2017","journal-title":"Eur Heart J."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1016\/j.jacc.2019.07.069","article-title":"Novel transcatheter mitral valve prosthesis for patients with severe mitral annular calcification","volume":"74","author":"Sorajja","year":"2019","journal-title":"J Am Coll Cardiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1016\/j.jacc.2018.02.054","article-title":"1-year outcomes of transcatheter mitral valve replacement in patients with severe mitral annular calcification","volume":"71","author":"Guerrero","year":"2018","journal-title":"J Am Coll Cardiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1016\/j.jcmg.2020.03.013","article-title":"A cardiac computed tomography-based score to categorize mitral annular calcification severity and predict valve embolization","volume":"13","author":"Guerrero","year":"2020","journal-title":"JACC Cardiovasc Imaging."},{"key":"B23","article-title":"Transapical transcatheter mitral valve implantation in patients with prior aortic valve replacement: a feasibility report","volume-title":"EuroIntervention.","author":"Taramasso","year":"2020"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2020.592909\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T09:05:36Z","timestamp":1608714336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2020.592909\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,23]]},"references-count":23,"alternative-id":["10.3389\/fcvm.2020.592909"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2020.592909","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,23]]},"article-number":"592909"}}